arrow
返回
R

Ronald M. Bukowski

University of Cambridge

90H指数
729论文数
4.5W被引数
收录论文 114
发表时间
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma
err2016-11-15
err58
errOAAI
errRini, Brian I.; McDermott, David F.; Hammers, Hans; Bro, William; Bukowski, Ronald M.; Faba, Bernard; Faba, Jo; Figlin, Robert A.; Hutson, Thomas; Jonasch, Eric; Joseph, Richard W.; Leibovich, Bradley C.; Olencki, Thomas; Pantuck, Allan J.; Quinn, David I.; Seery, Virginia; Voss, Martin H.; Wood, Christopher G.; Wood, Laura S.; Atkins, Michael B.
err分享
err收藏
Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN projectaEuro
err2015-12-01
err23
errOAAI
errKramar, A.; Negrier, S.; Sylvester, R.; Joniau, S.; Mulders, P.; Powles, T.; Bex, A.; Bonnetain, F.; Bossi, A.; Bracarda, S.; Bukowski, R.; Catto, J.; Choueiri, T. K.; Crabb, S.; Eisen, T.; El Demery, M.; Fitzpatrick, J.; Flamand, V.; Goebell, P. J.; Gravis, G.; Houede, N.; Jacqmin, D.; Kaplan, R.; Malavaud, B.; Massard, C.; Melichar, B.; Mourey, L.; Nathan, P.; Pasquier, D.; Porta, C.; Pouessel, D.; Quinn, D.; Ravaud, A.; Rolland, F.; Schmidinger, M.; Tombal, B.; Tosi, D.; Vauleon, E.; Volpe, A.; Wolter, P.; Escudier, B.; Filleron, T.
err分享
err收藏
Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma
err2015-06-18
err159
errOAAI
errGore, M. E.; Szczylik, C.; Porta, C.; Bracarda, S.; Bjarnason, G. A.; Oudard, S.; Lee, S-H; Haanen, J.; Castellano, D.; Vrdoljak, E.; Schoeffski, P.; Mainwaring, P.; Hawkins, R. E.; Crino, L.; Kim, T. M.; Carteni, G.; Eberhardt, W. E. E.; Zhang, K.; Fly, K.; Matczak, E.; Lechuga, M. J.; Hariharan, S.; Bukowski, R.
err分享
err收藏
Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma
err2014-01-16
err61
errOAAI
errHutson, T. E.; Bukowski, R. M.; Rini, B. I.; Gore, M. E.; Larkin, J. M.; Figlin, R. A.; Barrios, C. H.; Escudier, B.; Lin, X.; Fly, K.; Martell, B.; Matczak, E.; Motzer, R. J.
err分享
err收藏
The Cost of Hope: A Candid Roundtable Discussion
err2013-05-23
err0
errOAAI
errBennett, Amanda; Bukowski, Ronald M.; Flaherty, Keith; Muir, J. Cameron; Turner, Craig D.
err分享
err收藏
Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma舒尼替尼治疗转移性肾细胞癌1059例预后因素分析
err2013-05-21
err119
errOAAI
errMotzer, R. J.; Escudier, B.; Bukowski, R.; Rini, B. I.; Hutson, T. E.; Barrios, C. H.; Lin, X.; Fly, K.; Matczak, E.; Gore, M. E.
err分享
err收藏
Potential mechanisms of resistance to targeted agents in human clear cell renal cell carcinoma
err2013-03-04
err0
PREAI
errGrozav, Adrian G.; Vaziri, Susan A. J.; Eric, Koegle R.; Grabowski, Dale R.; Bukowski, Ronald M.; Ganapathi, Mahrukh K.; Ganapathi, Ram N.
err分享
err收藏
Improvement in Overall Survival of Patients with Advanced Renal Cell Carcinoma: Prognostic Factor Trend Analysis from an International Data Set of Clinical Trials
err2012-12-01
err44
PREAI
errPatil, Sujata; Manola, Judith; Elson, Paul; Negrier, Sylvie; Escudier, Bernard; Eisen, Tim; Atkins, Michael; Bukowski, Ronald; Motzer, Robert J.
err分享
err收藏
ICUD-EAU International Consultation on Kidney Cancer 2010: Treatment of Metastatic Disease
err2011-10-01
err123
PREAI
errPatard, Jean-Jacques; Pignot, Geraldine; Escudier, Bernard; Eisen, Tim; Bex, Axel; Sternberg, Cora; Rini, Brian; Roigas, Jan; Choueiri, Toni; Bukowski, Ronald; Motzer, Robert; Kirkali, Ziya; Mulders, Peter; Bellmunt, Joaquim
err分享
err收藏
err分享
err收藏
Prognostic Model for Survival in Patients with Metastatic Renal Cell Carcinoma: Results from the International Kidney Cancer Working Group
err2011-08-14
err153
errOAAI
errManola, Judith; Royston, Patrick; Elson, Paul; McCormack, Jennifer Bacik; Mazumdar, Madhu; Negrier, Sylvie; Escudier, Bernard; Eisen, Tim; Dutcher, Janice; Atkins, Michael; Heng, Daniel Y. C.; Choueiri, Toni K.; Motzer, Robert; Bukowski, Ronald
err分享
err收藏
Phase I/II trial of subcutaneous interleukin-2, granulocyte-macrophage colony-stimulating factor and interferon-α in patients with metastatic renal cell carcinoma
err2011-01-18
err11
PREAI
errGarcia, Jorge A.; Mekhail, Tarek; Elson, Paul; Wood, Laura; Bukowski, Ronald M.; Dreicer, Robert; Rini, Brian I.
err分享
err收藏
Sequential use of targeted agents in the treatment of renal cell carcinoma
err2011-01-01
err50
PREAI
errHutson, Thomas E.; Bukowski, Ronald M.; Cowey, C. Lance; Figlin, Robert; Escudier, Bernard; Sternberg, Cora N.
err分享
err收藏
Sorafenib in Patients With Metastatic Renal Cell Carcinoma Refractory to Either Sunitinib or Bevacizumab
errCANCER
IF5.1
err2010-11-29
err58
errOAAI
errGarcia, Jorge A.; Hutson, Thomas E.; Elson, Paul; Cowey, C. Lance; Gilligan, Timothy; Nemec, Cheryl; Dreicer, Robert; Bukowski, Ronald M.; Rini, Brian I.
err分享
err收藏
Clinical and immunomodulatory effects of bevacizumab and low-dose interleukin-2 in patients with metastatic renal cell carcinoma: results from a phase II trial
err2010-09-14
err19
PREAI
errGarcia, Jorge A.; Mekhail, Tarek; Elson, Paul; Triozzi, Pierre; Nemec, Cheryl; Dreicer, Robert; Bukowski, Ronald M.; Rini, Brian I.
err分享
err收藏
Long-term safety of sorafenib in advanced renal cell carcinoma: Follow-up of patients from phase III TARGET索拉非尼在晚期肾细胞癌中的长期安全性: 来自III期目标的患者的随访
err2010-09-01
err67
PREAI
errHutson, Thomas E.; Bellmunt, Joaquim; Porta, Camillo; Szczylik, Cezary; Staehler, Michael; Nadel, Andrea; Anderson, Sibyl; Bukowski, Ronald; Eisen, Tim; Escudier, Bernard
err分享
err收藏
A phase II study of tandutinib (MLN518), a selective inhibitor of type III tyrosine receptor kinases, in patients with metastatic renal cell carcinoma
err2010-08-14
err14
PREAI
errShepard, Dale R.; Cooney, Matthew M.; Elson, Paul; Bukowski, Ronald M.; Dreicer, Robert; Rini, Brian I.; Garcia, Jorge A.
err分享
err收藏